Akebia Therapeutics saw the highest growth of 1.66% in patent filings and 1.49% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.59% and grants by 0.39%. GlobalData’s DataBook provides a comprehensive analysis of Akebia Therapeutics’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Akebia Therapeutics has been focused on protecting inventions in European Patent Office(EPO) with three publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings with nearly 25% of filings. The United States(US), European Patent Office(EPO), Argentina(AR), and China(CN) patent Office are among the top ten patent offices where Akebia Therapeutics is filings its patents. Among the top granted patent authorities, Akebia Therapeutics has 20% of its grants in Australia(AU).
Sanofi and Merck could be the strongest competitors for Akebia Therapeutics
Patents related to rare diseases lead Akebia Therapeutics's portfolio
Akebia Therapeutics has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and 100% of patents were granted in Q2 2024.
Anemia related patents lead Akebia Therapeutics portfolio followed by chronic kidney disease (chronic renal failure), and mobiles, hand-helds, pdas, smartphones
Akebia Therapeutics has highest number of patents in anemia followed by chronic kidney disease (chronic renal failure), mobiles, hand-helds, pdas, smartphones, hypoxia, and kidney disease (nephropathy). For anemia, nearly 31% of patents were filed and 24% of patents were granted in Q2 2024.
For comprehensive analysis of Akebia Therapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
